Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease

BACKGROUND: Ongoing efforts within the Alzheimer’s disease (AD) field have focused on improving the intra- and inter-laboratory variability for cerebrospinal fluid (CSF) biomarkers. Fully automated assays offer the possibility to eliminate sample manipulation steps and are expected to contribute to...

Descripción completa

Detalles Bibliográficos
Autores principales: Leitão, Maria João, Silva-Spínola, Anuschka, Santana, Isabel, Olmedo, Veronica, Nadal, Alicia, Le Bastard, Nathalie, Baldeiras, Inês
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875031/
https://www.ncbi.nlm.nih.gov/pubmed/31759396
http://dx.doi.org/10.1186/s13195-019-0550-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875031/
https://www.ncbi.nlm.nih.gov/pubmed/31759396
http://dx.doi.org/10.1186/s13195-019-0550-8

Ejemplares similares